Evaluation of an RNAseq-based immunogenomic liquid biopsy approach in early-stage prostate cancer

Immunology and Microbiology

• Prostate Specific Antigen 100%
• Prostate 100%
• Adoptive Immunity 50%
• Immunosurveillance 50%
• Transcriptome 50%
• CD2 50%
• RNA Sequence 50%
• Transcriptomics 50%
• Gene Expression 50%
• Immunocompetent Cell 50%
• Age 50%
• Phagocytosis 50%
• CD14 50%
• Gene Expression Level 50%

Keyphrases

• Immunogenomics 100%
• Circulating Immune Cells 50%
• Clinically Significant Prostate Cancer 50%
• Adverse Pathologic Features 50%
• Tumor Immune Microenvironment 50%
• Prostate-specific Antigen Density 50%
• Clinical Risk Factors 50%
• Digital Rectal Examination 50%
• Adverse Pathology 50%
• Traditional Clinical 50%
• Independent Training 50%
• Whole Transcriptome RNA Sequencing 50%